Kazakhstan vs Republic of Moldova: HIV-positive TB patients on ART (antiretroviral therapy)
Kazakhstan
87.0%
in 2024
Republic of Moldova
88.0%
in 2024
Kazakhstan rank
102nd
Republic of Moldova rank
100th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Kazakhstan
- Republic of Moldova
How they compare
Republic of Moldova currently reports 88.0% against 87.0% in Kazakhstan, a difference of 1.0%.
The two have swapped places 6 times across 17 shared years of data; in 2006 it was Republic of Moldova ahead.
Kazakhstan ranks 102nd and Republic of Moldova ranks 100th of 144 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 2 and Republic of Moldova in 1.
Head to head by decade
| Decade | Kazakhstan | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.7% | 44.3% | 31.7% | Republic of Moldova |
| 2010s | 71.3% | 59.3% | 11.9% | Kazakhstan |
| 2020s | 91.0% | 85.6% | 5.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Kazakhstan or Republic of Moldova?
- Republic of Moldova, at 88.0% against 87.0% in Kazakhstan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Kazakhstan and Republic of Moldova?
- 1.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Kazakhstan and Republic of Moldova?
- 17 years are reported by both, from 2006 to 2024.
- How do Kazakhstan and Republic of Moldova rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Kazakhstan ranks 102nd and Republic of Moldova ranks 100th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.